carbostyril has been researched along with Sicca Syndrome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
JeongWon, C; Jin-Sil, P; Kyung-Ah, J; Mi-La, C; SeungCheon, Y; Sun-Hee, H; Sung-Hwan, P | 1 |
Inada, N; Shoji, J; Tomioka, A; Yamagami, S | 1 |
Ahuja, M; Bridges, RJ; Chiorini, JA; Muallem, S; Swaim, W; Szymczak, M; Yin, H; Zeng, M; Zheng, C | 1 |
Arakaki, R; Eguchi, H; Enkhmaa, T; Hayashi, Y; Hotta, F; Ishimaru, N; Iwasa, A; Kudo, Y; Mitamura, Y; Mitamura-Aizawa, S; Yamada, A | 1 |
Arimoto, A; Kitagawa, K; Mita, N; Sasaki, H; Shibuya, E; Takahashi, Y | 1 |
Kapoor, S | 1 |
Kawakami, A; Koni, I; Nishinarita, M; Nishiyama, S; Ohta, S; Oka, H; Sawada, S; Sugai, S; Sugiyama, E; Takahashi, H; Takei, M; Umehara, H; Yamaji, K | 1 |
Arakaki, R; Hayashi, Y; Ishimaru, N; Kohashi, M | 1 |
2 trial(s) available for carbostyril and Sicca Syndrome
Article | Year |
---|---|
Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.
Topics: Adult; Aged; Aged, 80 and over; Alanine; CA-125 Antigen; Female; Gene Expression Regulation; Humans; Male; Membrane Proteins; Middle Aged; Mucin 5AC; Ophthalmic Solutions; Prospective Studies; Proto-Oncogene Proteins c-ets; Quinolones; Sjogren's Syndrome | 2020 |
Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial.
Topics: Aged; Alanine; Anti-Inflammatory Agents; Double-Blind Method; Eating; Female; Humans; Male; Middle Aged; Mouth; Prostaglandins; Quinolones; Saliva; Sjogren's Syndrome; Sleep; Treatment Outcome; Xerostomia | 2009 |
6 other study(ies) available for carbostyril and Sicca Syndrome
Article | Year |
---|---|
Immune modulation by rebamipide in a mouse model of Sjogren's syndrome via T and B cell regulation.
Topics: Alanine; Animals; B-Lymphocytes, Regulatory; Cytokines; Disease Models, Animal; Immunomodulation; Mice; Oxygenases; Quinolones; Salivary Glands; Sjogren's Syndrome; Th17 Cells | 2019 |
Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.
Topics: Acinar Cells; Aminophenols; Animals; Aquaporin 5; Autoimmune Diseases; Bone Morphogenetic Protein 6; Calcium Signaling; Chloride Channel Agonists; Cyclopropanes; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Female; Genetic Therapy; Inositol 1,4,5-Trisphosphate Receptors; Mice, Inbred MRL lpr; Mice, Inbred NOD; ORAI1 Protein; Pancreas; Pancreatitis; Quinolones; Recovery of Function; Salivary Glands; Salivation; Sjogren's Syndrome; Time Factors; Tissue Culture Techniques; Transduction, Genetic; Up-Regulation | 2017 |
Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.
Topics: Administration, Ophthalmic; Alanine; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; Drug Administration Schedule; Female; Gene Expression Regulation; Humans; Interleukin-10; Keratoconjunctivitis; Lacrimal Apparatus; Lactoferrin; Mice; Mucin 5AC; Quinolones; Sjogren's Syndrome | 2014 |
Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antibodies, Antinuclear; Antioxidants; Autoantibodies; Eyelids; Female; Fluorophotometry; Humans; Keratoconjunctivitis Sicca; Male; Middle Aged; Mucins; Nasolacrimal Duct; Ophthalmic Solutions; Purinergic P2Y Receptor Agonists; Quinolones; Sjogren's Syndrome; Suspensions; Tears | 2014 |
Sjogren's syndrome: promising, new treatment options besides nizatidine.
Topics: Alanine; Antioxidants; Flax; Histamine H2 Antagonists; Humans; Nizatidine; Plant Preparations; Quinolones; Seeds; Sjogren's Syndrome; Treatment Outcome | 2009 |
Effective treatment with oral administration of rebamipide in a mouse model of Sjögren's syndrome.
Topics: Administration, Oral; Alanine; Animals; Anti-Inflammatory Agents; Autoantibodies; Cell Division; Cytokines; Disease Models, Animal; Female; Immunologic Factors; Lacrimal Apparatus; Mice; Mice, Mutant Strains; Quinolones; Salivary Glands; Sjogren's Syndrome; T-Lymphocytes; Thymectomy | 2008 |